Characterization of near full-length genomes of HIV type 1 strains in Denmark: Basis for a universal therapeutic vaccine

AIDS Research and Human Retroviruses

Volumn 23, Issue 11, 2007, Pages 1442-1448

  Andresen, Betina S ^a   Vinner, Lasse ^a   Tang, Sheila ^b   Bragstad, Karoline ^a   Kronborg, Gitte ^c   Gerstoft, Jan ^d   Corbet, Sylvie ^a   Fomsgaard, Anders ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VIRUS VACCINE; HLA A ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; DENMARK; DNA EXTRACTION; GENE DELETION; GENE INSERTION; GENE ISOLATION; GENE REARRANGEMENT; GENOME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION PROCEDURE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PRIORITY JOURNAL; VIRUS CHARACTERIZATION; VIRUS LOAD; VIRUS STRAIN; CLASSIFICATION; DNA SEQUENCE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; MIDDLE AGED; MOLECULAR GENETICS; MONONUCLEAR CELL; SEQUENCE HOMOLOGY; VIROLOGY; VIRUS GENOME;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; DENMARK; DNA, VIRAL; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIRAL LOAD;

EID: 38449100601     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0111     Document Type: Article

References (19)

1. Jorgensen LB, Christensen MB, Gerstoft J, et al.: Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark. Scand J Infect Dis 2003;35(11-12):800-807.
2. Borrow P, Lewicki H, Hahn BH, Shaw GM, and Oldstone MB: Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68(9):6103-6110.
3. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994;68(7):4650-4655.
4. Musey L, Hughes J, Schacker T, et al.: Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997;337(18):1267-1274.
5. McMichael AJ. HIV vaccines. Annu Rev Immunol 2006;24:227-255.
6. Thorn M, Tang S, Therrien D, et al.: Sequence conservation of subdominant HLA-A2-binding CTL epitopes in HIV-1 clinical isolates and CD8+ T-lymphocytes cross-recognition may explain the immune reaction in infected individuals. APMIS 2007;115(6):757-768.
7. Frahm N, Kiepiela P, Adams S, et al.: Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes 2. Nat Immunol 2006;7(2):173-178.
8. Mason D: A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998;19(9):395-404.
9. Corbet S, Nielsen HV, Vinner L, et al.: Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes. J Gen Virol 2003;84(Pt. 9):2409-2421.
10. Salminen MO, Koch C, Sanders-Buell E, et al.: Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology 1995;213(1):80-86.
11. Los Alamos database: Internet Communication, 2007.
12. Kumar S, Tamura K, and Nei M: MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 2004;5(2):150-163.
13. Jorgensen LB, Bøgh M, Machuca R, and Nielsen C: Genotypic and phenotypic resistance in HIV isolated by culture reflect the genotype and phenotype of viral RNA in plasma. Unpublished work, 2007.
14. Graham BS and Wright PF: Candidate AIDS vaccines. Drug Ther 1995;333[20]:1331-1339.
15. Jorgensen LB, Christensen MB, Gerstoft J, et al.: Prevalence of drug resistance mutations and non-B subtypes in newly diagnosed HIV-1 patients in Denmark. Scand J Infect Dis 2007;35:800-807.
16. Kan-Mitchell J, Bisikirska B, Wong-Staal F, et al.: The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol 2004;172(9):5249-5261.
17. Goulder PJ, Altfeld MA, Rosenberg ES, et al.: Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J Exp Med 2001;193(2):181-194.
18. Brander C, Yang OO, Jones NG, et al.: Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. J Virol 1999;73(12):10191-10198.
19. Brander C, Hartman KE, Trocha AK, et al.: Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest 1998;101(11):2559-2566.